| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082721 | Drug Discovery Today: Technologies | 2006 | 9 Pages |
Abstract
Proteins are the molecular players of fine-tuned regulatory pathways that underlie the behavior of any cell type. Derangement of this wide protein circuitry has a profound effect on cell life and ultimately contributes to the development of diseases such as cancer. New proteomic technologies are rapidly evolving to define and characterize the nodes of this altered protein network, both inside and outside cancer cells. Hopefully, these technologies will become user-friendly laboratory tools to improve cancer management from early detection to the development of rational and patient-tailored therapeutic strategies.
Section editor:Hugo Kubinyi – University of Heidelberg, Heidelberg, Germany
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Simona Fontana, Giacomo De Leo, Mirela Sedic, Sandra Kraljevic Pavelic, Riccardo Alessandro,